Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Psychosis, Schizophrenia, First-episode Psychosis
In brief
Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.
Key facts
- Study ID
- NCT04368039
- Run by
- Nicholas Breitborde
- People needed
- 20
- Starts
- 2019-12-04
- Expected to finish
- 2026-12-07
- Last updated by the study team
- 2026-02-25
Who can join
Age: 15 and older, up to 35. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Harding Hospital — Columbus, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.